Suppliers / Polymed Therapeutics

Polymed Therapeutics

United States 4 employees Updated 9 July 2026

Polymed Therapeutics is an API manufacturer based in United States. It holds 2 active US drug master files and 3 valid CEPs across a filed portfolio of 4 molecules. Its filings concentrate with EMA and AIFA (IT).

2
active US DMFs
3
valid CEPs
1
registered plants
2
filings across 2 regulators

Registered plants

Site FDA FEI
Houston, United States Not on file

What they file, and where

Molecule Regulators Docs
Docetaxel EDQM, SFDA (Saudi Arabia) 2
Paclitaxel EDQM 2
Carfilzomib US FDA 1
Pemetrexed US FDA 1

Also appears on these molecule pages

Carfilzomib API Docetaxel API Paclitaxel API Pemetrexed API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 1 None
AIFA (IT) 1 None

Questions about Polymed Therapeutics

Does Polymed Therapeutics hold a US DMF or a CEP?
Polymed Therapeutics holds 2 active US drug master files and 3 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Polymed Therapeutics manufacture?
1 registered site is on record, in United States (Houston). Every site is listed on this page with the register it came from.
What does Polymed Therapeutics make?
4 molecules are on record against Polymed Therapeutics, including Docetaxel, Paclitaxel, Carfilzomib and Pemetrexed. Each links through to that molecule's full manufacturer list.
Where does Polymed Therapeutics file?
Filings are on record with EMA and AIFA (IT), 2 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Polymed Therapeutics comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 4 molecules Hetero shares 4 molecules Chongqing Sintaho Pharmaceutical shares 4 molecules Dr Reddy's Laboratories shares 3 molecules Laurus Labs shares 3 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability